Ability to Drive of Early Stage Alzheimer Disease (DRIVE COG)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01566071|
Recruitment Status : Completed
First Posted : March 29, 2012
Last Update Posted : June 9, 2016
The main objectives of this study are:
- To evaluate the driving capacities in a population of elderly subjects with early stage Alzheimer Disease (AD) in a real-life situation.
- Define a typology of the main errors made in this population.
- Propose adaptive measures or technological aids that would make it possible for these patients to maintain their ability to drive a car while limiting risk.
|Condition or disease||Intervention/treatment||Phase|
|Alzheimer Disease||Other: Assessment of drive abilities||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||60 participants|
|Intervention Model:||Single Group Assignment|
|Study Start Date :||July 2012|
|Actual Study Completion Date :||July 2015|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01566071
|CHU de REIMS|
|Reims, France, 51092|
|Principal Investigator:||JEAN-LUC NOVELLA, MD PhD||CHU de Reims|